MoneyWorks4Me

Windlas Biotech - Quaterly Results

08 Nov 2023 Evaluate
A fair growth of 15.02% in the revenue at Rs. 1526.72 millions was reported in the September 2023 quarter as compared to Rs. 1327.30 millions during year-ago period.The Company has registered profit of Rs. 140.31  millions for the quarter ended September 2023, a growth of 14.92%  over Rs. 122.09 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended September 2023 rose to 219.27 millions as compared to 186.70 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1526.72 1327.30 15.02 2974.58 2526.66 17.73 5130.83 4659.30 10.12
Other Income 32.40 26.11 24.09 58.64 54.69 7.22 99.65 67.06 48.60
PBIDT 219.27 186.70 17.45 416.94 353.20 18.05 702.07 596.01 17.80
Interest 2.85 1.15 147.83 5.22 4.65 12.26 7.86 14.17 -44.53
PBDT 216.42 185.55 16.64 411.72 348.55 18.12 694.21 581.84 19.31
Depreciation 33.30 29.05 14.63 65.19 56.61 15.16 123.64 121.47 1.79
PBT 183.12 156.50 17.01 346.53 291.94 18.70 570.57 460.37 23.94
TAX 42.81 34.41 24.41 85.56 71.85 19.08 144.13 74.76 92.79
Deferred Tax -0.91 -2.86 -68.18 2.03 -1.90 -206.84 0.63 -26.57 -102.37
PAT 140.31 122.09 14.92 260.97 220.09 18.57 426.44 385.61 10.59
Equity 103.99 108.97 -4.57 103.99 108.97 -4.57 104.63 108.97 -3.98
PBIDTM(%) 14.36 14.07 2.10 14.02 13.98 0.27 13.68 12.79 6.97
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..